Do beta adrenoceptor blocking agents provide the same degree of clinically convincing morbidity and mortality benefits in patients with chronic heart failure? A literature review
Crossref DOI link: https://doi.org/10.29328/journal.jccm.1001063
Published Online: 2019-11-04
Update policy: https://doi.org/10.29328/crossmark-policy
Danaah Malick, Martin Mumuni
License valid from 2019-11-04
Version of Record valid from 2013-11-25
Accepted Manuscript valid from 2016-04-18